BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant

New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally signif...

July 28, 2021 | News

DePuy Synthes Unveils VELYS™ Robotic-Assisted Solution In Australia

Australian orthopaedic surgeons to be among the first in the world to access DePuy Synthes’ VELYS Robotic-Assisted Solution, which has recently been ...

July 20, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

July 08, 2021 | News

Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara

Alvotech, today, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT...

July 06, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

July 02, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

July 01, 2021 | News

Australia's Qbiotics concludes successful $85 million capital raise

Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners. Fun...

June 28, 2021 | News

Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants

The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...

June 18, 2021 | News

ENA Respiratory secured up to AU$32m investment to Advances COVID-19 Preventative Therapy

Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company a...

June 16, 2021 | News

Sermo Acquires Minter Group to connect the pharmaceutical industry In APAC

Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...

June 15, 2021 | News

Viraleze registered for sale in Covid-ravaged India

The announcement came as the world's second most populous country battles a devastating second wave of COVID-19 infections, with over 29 million cases and ...

June 14, 2021 | News

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited

Theramex UK Ltd announces a license and supply agreement with Enzene Biosciences Limited, for the registration and commercialisation of denosumab, an antir...

June 10, 2021 | News

Australian researchers lead world in successful trial of new cancer treatment

Relatlimab is the first immunotherapy treatment to target LAG-3, a protein in immune cells which reinvigorates and enhances the tumour fighting r...

June 07, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

June 04, 2021 | Analysis

Stay Connected